cutA Antibody

Datasheet

Code	CSB-PA291235XA01ENV
Size	Enquire
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Customer Reviews and Q&A
Target Background

Product Details

Full Product Name

Rabbit anti-Escherichia coli (strain K12) cutA Polyclonal antibody

Uniprot No.

P69488

Target Names

cutA

Alternative Names

cutA antibody; cutA1 antibody; cycY antibody; b4137 antibody; JW4097Divalent-cation tolerance protein CutA antibody; C-type cytochrome biogenesis protein CycY antibody

Raised in

Rabbit

Species Reactivity

Escherichia coli (strain K12)

Immunogen

A synthesized peptide derived from Escherichia coli (strain K12) cutA protein

Immunogen Species

Escherichia coli (strain K12)

Conjugate

Non-conjugated

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form

Liquid

Tested Applications

ELISA, Dot blot (guaranteed specific to the immunizing peptide)

Protocols

ELISA Protocol

Troubleshooting and FAQs

Antibody FAQs

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Value-added Deliverables

①. 100ug * KLH-conjugated peptide paired with 100ug * BSA-conjugated peptide (positive control);
②. 1ml*pre-immune serum (used as negative control) for free;
③. Rabbit polyclonal antibodies purified by Antigen Affinity;

Quality Guarantee

1. CUSABIO guarantees the antibody purity > 95% confirmed by SDS-PAGE.
2. CUSABIO guarantees the antibody titer > 1: 64,000 confirmed by ELISA.
3. CUSABIO guarantees to offer Peptide-specific Dot blot.
4. CUSABIO guarantees 100% risk-free: No qualified antibody, no charge.

Lead Time

Made-to-order (14-16 weeks)

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function

Involved in resistance toward heavy metals.

Gene References into Functions

Data show that the stability of Escherichia coli CutA1 is remarkably improved by slight substitutions, and that remarkable improvements in stability can be quantitatively explained based on the newly solved native structure. PMID: 20639520
structural characterization of CutA1 in solution by NMR PMID: 17847095

Subcellular Location

Cytoplasm.

Protein Families

CutA family

Database Links

KEGG: ecj:JW4097

STRING: 316385.ECDH10B_4330

Promotions

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Melanoma, the Most Serious Type of Skin Cancer Chemokine Receptor CCR4: the Key Role of CCR4+Treg Cells in Cancer Immunotherapy The Collection of Progress of Anti-GPCR Antibody Drugs Differentiation of Th17 Cells and Their Roles in Health and Disease DKK1: a Well-Characterized Wnt Inhibitor, a Multifunctional Regulator in Multiple Cancers! CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! GIPR: the Crucial Regulator of Glucose and Lipid Metabolism in Diabetes and Obesity! CD48: An Emerging Human Immune Co-stimulatory Molecule, Friend or Foe? CD146, A Powerful Tumor Marker GPCR Drugs Discovery The Overview of Chemokine Another powerful addition to domestic IL-17A inhibitors! 3S Guojian's Anmoqitamab approved, with once-every-8-week dosing—a game-changer for psoriasis patients. PD-1/PD-L1, What a Powerful Immune Checkpoint The overview of TGF-β signaling pathway CCR9: A Member of the Chemokine Receptor Family, an Emerging Target for Numerous Tumor Researches! Chemokine Receptor CCR6: the Specific Receptor for CCL20, a Potential Target for Drug Research in Inflammatory Diseases and Gastrointestinal Cancer! What Should You Know about Exosomes? BDCA2/CLEC4C: a Novel Plasma Cell-Like Dendritic Cell (pDC) Marker and Potent Inhibitor of IFN-I that Blocks SLE Development! ENPP3 (CD203c): An Extracellular Enzyme, a Regulator for Nucleotide and Energy, an Indicator for Allergies, an Effective Target for RCC Therapy! CADM1: an Immunoglobulin Superfamily Molecule, a New Tumor Suppressor Gene! DSG3: An Emerging Tumor-Associated Adhesion Factor, a Specific Marker for the Clinical Diagnosis of Pemphigus Vulgaris (PV)! Nectin-4: a Key Target in the IgSF Family, Boosting Clinical Drug Research in Various Tumors! IL2's 'Double-Edged Sword' Strikes Again: PD1/IL2/VEGF Trispecific Antibodies Emerge at AACR 2026, Nektar's Autoimmune Data Sparks Heated Discussion PTH1R: Key Therapeutic Target in Bone & Metabolic Health LAG3: The Next Frontier in Tumor Immunotherapy FCGR3A: A Key Receptor for Immune Regulation Overview of CCR4 Target: Core Roles in Physiological Functions and Pathological Regulation CD4 Molecule: A Review of Structural Characteristics, T Cell Subsets, Signaling Pathways, Disease Associations and Progress in Targeted Drug Development CD40LG: A Key Molecule in Immune Regulation, Disease Associations and Therapeutic Progress Fibroblast Growth Factor 2 (FGF2): Molecular Mechanisms, Signaling Pathways, Disease Associations and Therapeutic Advances The CD200/CD200R Signaling Axis: A Critical “Brake” in Maintaining Immune Homeostasis Beyond PD-1: CD96 is Becoming the Next "Battleground" in Immunotherapy Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：
Please enter the characters shown. Click the image to refresh if unclear.